Medical Marijuana & Research

Covers laws and regulations governing medical marijuana programs and related scientific research, including patient access, physician recommendations, licensing and compliance for dispensaries and laboratories, clinical trials, and handling and prescribing rules. Also addresses conflicts between state and federal law, funding and approvals, intellectual property, and liability or enforcement risks for researchers and providers.

1 post

The Marijuana Rescheduling Decision – What Schedule III Really Means

May 1, 2026 • By Jack Gilbert

Rescheduling marijuana to Schedule III would recognize accepted medical use under federal law and place it with drugs like ketamine and Tylenol with codeine. It would ease research barriers and can eliminate IRC 280E tax burdens for federally lawful businesses, but it would not legalize recreational marijuana nationwide. This article explains what Schedule III means, […]